TLR4 and diabetic cardiomyopathy: However, treatment with BMP-7 attenuates the expression of TLR4 (Figure 2D, p = 0.027) and NLRP3 (Figure 2F, p = 0.033) compared to the STZ-induced diabetic cardiomyopathy.